17 related articles for article (PubMed ID: 21184276)
1. BRCA2 T2722R is a deleterious allele that causes exon skipping.
Fackenthal JD; Cartegni L; Krainer AR; Olopade OI
Am J Hum Genet; 2002 Sep; 71(3):625-31. PubMed ID: 12145750
[TBL] [Abstract][Full Text] [Related]
2. BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation.
Thirthagiri E; Klarmann KD; Shukla AK; Southon E; Biswas K; Martin BK; North SL; Magidson V; Burkett S; Haines DC; Noer K; Matthai R; Tessarollo L; Loncarek J; Keller JR; Sharan SK
Hum Mol Genet; 2016 May; 25(10):1934-1945. PubMed ID: 26920070
[TBL] [Abstract][Full Text] [Related]
3. BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.
Nielsen HR; Nilbert M; Petersen J; Ladelund S; Thomassen M; Pedersen IS; Hansen TV; Skytte AB; Borg Å; Therkildsen C
Fam Cancer; 2016 Oct; 15(4):507-12. PubMed ID: 26833046
[TBL] [Abstract][Full Text] [Related]
4. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
[TBL] [Abstract][Full Text] [Related]
5. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.
Claes K; Poppe B; Machackova E; Coene I; Foretova L; De Paepe A; Messiaen L
Genes Chromosomes Cancer; 2003 Jul; 37(3):314-20. PubMed ID: 12759930
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
Thomassen M; Hansen TV; Borg A; Lianee HT; Wikman F; Pedersen IS; Bisgaard ML; Nielsen FC; Kruse TA; Gerdes AM
Acta Oncol; 2008; 47(4):772-7. PubMed ID: 18465347
[TBL] [Abstract][Full Text] [Related]
7. BRCA2 founder mutation in Slovenian breast cancer families.
Krajc M; De Grève J; Goelen G; Teugels E
Eur J Hum Genet; 2002 Dec; 10(12):879-82. PubMed ID: 12461697
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin.
Infante M; Durán M; Acedo A; Pérez-Cabornero L; Sanz DJ; García-González M; Beristain E; Esteban-Cardeñosa E; de la Hoya M; Teulé A; Vega A; Tejada MI; Lastra E; Miner C; Velasco EA
Clin Genet; 2010 Jan; 77(1):60-9. PubMed ID: 19912264
[TBL] [Abstract][Full Text] [Related]
9. A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing.
Thomassen M; Pedersen IS; Vogel I; Hansen TV; Brasch-Andersen C; Brasen CL; Crüger D; Sunde L; Nielsen FC; Jensen UB; Bisgaard ML; Borg A; Gerdes AM; Kruse TA
Breast Cancer Res Treat; 2011 Jul; 128(1):179-85. PubMed ID: 21184276
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
